Daily News Watch

News Home Page

Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.

bioTheranostics Raises $32 Million in Private Equity Financing and Announces Spinout From bioMérieux

bioTheranostics, a leader in molecular diagnostics for cancer, recently announced that it has closed a $32 million financing led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and HealthQuest Capital. As a result of the financing, bioTheranostics will be spun out from bioMérieux, which will remain a minority shareholder, and operate as an independent company."This is an exciting new beginning for bioTheranostics," said Nicolas Barthelemy, president and CEO of ...

Posted on: February 08, 2016
Irradiated Anthrax Can Be Sequenced - Fast!

These days, mail addressed to selected government offices gets irradiated in order to kill any biological agents, notably anthrax spores. The downside of this is that viable spores have been needed to identify the anthrax strain, which can be critical to treating those infected. But now Henry S. Gibbons, PhD, has shown that full sequences can quickly be determined from irradiated spores. The research was published November 13th, 2015, in Applied and Environmental Microbiology, a journal of the American ...

Posted on: February 05, 2016
New Malaria Test Sets a New Gold Standard for Diagnosis

Meridian Bioscience, Inc. (NASDAQ:VIVO) recently announced that it has received the CE Mark for illumigene Malaria, a novel, highly accurate  test developed by Meridian with the technical assistance of the Centers for Disease Control and Prevention (CDC) and Cheikh Anta Diop University of Dakar, Senegal. The test is up to 80,000 times more sensitive at detecting the malaria parasite than conventional tests, potentially revolutionizing malaria diagnosis and establishing a new gold standard. Using ...

Posted on: February 04, 2016
Leica Biosystems and Advanced Cell Diagnostics Partner to Develop and Commercialize RNAscope-based Diagnostic and Companion Diagnostic Tests

Leica Biosystems and Advanced Cell Diagnostics Partner to Develop and Commercialize RNAscope-based Diagnostic and Companion Diagnostic Tests Leica Biosystems, a global leader in anatomic pathology solutions and workflow automation, and Advanced Cell Diagnostics, Inc. (ACD), a world leader in RNA biomarker analysis for precision medicine, recently announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD's RNAscope in situ hybridization (ISH) assays on ...

Posted on: February 03, 2016
Dako Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma

Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, recently announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of the intended use of Dako PD-L1 IHC 28-8 pharmDx to include patients with melanoma.Dako's PD-L1 IHC 28-8 pharmDx diagnostic first received approval from the FDA on Oct. 9, 2015, for non-squamous, non-small cell lung cancer (NSCLC). The complementary test has now been expanded to include melanoma and may be used by physicians ...

Posted on: February 02, 2016
Rockin' Crystals in Dip&Spin!

Quantimetrix announces the introduction of a new formulation for Dip&Spin Urinalysis Dipstick/Microscopics Control. The new formulation now features improved crystal sediment component with Calcium Oxalate Dihydrate (COD) in their native octahedral morphology and are readily identifiable via standard light microscopy and automated microscopy methods, making them excellent control solutions for the clinical lab.Request a Free Sample.About QuantimetrixQuantimetrix, a family business since 1974, has been ...

Posted on: February 01, 2016
Gene Therapy: A Promising Candidate for Cystic Fibrosis Treatment

An improved gene therapy treatment can cure mice with cystic fibrosis (CF). Cell cultures from CF patients, too, respond well to the treatment. Those are the encouraging results of a study recently presented by the Laboratory for Molecular Virology and Gene Therapy at KU Leuven, Belgium.Cystic fibrosis (mucoviscidosis) is a genetic disorder that makes the mucus in the body thick and sticky, which in turn causes clogging in the airways and the gastrointestinal tract. The symptoms can be treated, but there ...

Posted on: January 29, 2016
Kibow Biotech Continues to Document the "Enteric Dialysis" Concept Towards Modulation of the Gut Microbiome With RENADYL

This year's annual American society of Nephrology (ASN) 2015 Kidney Week conference was held at the San Diego Convention Center, Nov 3-8.1 Kibow Biotech, Inc. was pleased to mark its 10th year of continuous participation as an exhibitor and to increase awareness and understanding of its "Enteric Dialysis or Uremic Toxin Reduction Technology" concept. The company's technology is based on modulating the Gut Microbiome with its dietary supplement product made with specific strains of Probiotics and selected ...

Posted on: January 28, 2016
AMP Symposium on Coding, Coverage and Reimbursement of Molecular Diagnostic Tests

The Association for Molecular Pathology (AMP), the premier global, professional society serving molecular diagnostics professionals, recently reported the results of a dynamic symposium, "Coding, Coverage and Reimbursement of Molecular Diagnostic Tests in Today's Healthcare Landscape," held November 6, 2015 at AMP's annual meeting in Austin, Texas.  The symposium was organized by AMP's Economic Affairs Committee (EAC).  At the symposium, Aaron D. Bossler, MD, PhD, 2015 EAC Chair, gave ...

Posted on: January 27, 2016
Proprietary Finger-Stick Cancer Monitoring Technology Launches Circulogene Theranostics into Liquid Biopsy Market

Proprietary Finger-Stick Cancer Monitoring Technology Launches Circulogene Theranostics into Liquid Biopsy Market Circulogene Theranostics has announced the commercial launch of its cell-free DNA (cfDNA) liquid biopsy products for the fast, accurate and personalized testing of 10 tumor types, including breast, lung and colon cancer. Circulogene becomes the first and only biotechnology company able to enrich circulating cfDNA from a single blood drop for patient-specific monitoring of cancer. Cell-free DNA ...

Posted on: January 26, 2016
New Board Members Poised to Shape the Agenda for AEHIX Groups

New Board Members Poised to Shape the Agenda for AEHIX GroupsThe Association for Executives in Healthcare Information Applications (AEHIA), Association for Executives in Healthcare Information Technology (AEHIT) and Association for Executives in Healthcare Information Security (AEHIS)-and their respective foundations-recently announced newly elected members to their boards of trustees.Launched in 2014 by the College of Healthcare Information Management Executives (CHIME), the groups-collectively known as ...

Posted on: January 25, 2016
Organizations Forge Alliance to Help Medical Industry Manage Aging Population Growth

Organizations Forge Alliance to Help Medical Industry Manage Aging Population GrowthZoeticx, Inc. and WellTrackONE Corp. have forged an agreement to bring long awaited interoperability to medical facilities' electronic health record (EHR) systems. The collaboration will enable Zoeticx's Patient-Clarity platform software to integrate WellTracksONES's Annual Wellness Visit (AWV) patient reports and associated medical data to any EHR, Health Information Exchange (HIE) or other data repository.The deal will ...

Posted on: January 22, 2016
94% Percent of Life Sciences Companies Planning an Acquisition in the Next Year, Over Two-Thirds Targeting Personalized Medicine

A global study of 100 senior executives at life sciences companies by global law firm Reed Smith, in partnership with Mergermarket, reveals that 94% are planning to make an acquisition in the next year, with 91% of US respondents expecting these to be cross-border transactions.The report, Life lines: Life sciences M&A and the rise of personalized medicine, explores the main drivers behind the pursuit of cross-border life sciences deals, the challenges faced in executing those deals, and how advances ...

Posted on: January 21, 2016
Miami Cancer Institute appoints Michael Zinner, MD

Michael J. Zinner, MD, a world-renowned and highly respected cancer surgeon and researcher, has been named founding CEO and executive medical director of Miami Cancer Institute at Baptist Health South Florida, announced Brian E. Keeley, president and CEO of Baptist Health South Florida."Dr. Zinner's credentials are indicative of the sophistication and high-quality medical care that Miami Cancer Institute will provide," Keeley said.  "Under his leadership, the Institute will deliver leading-edge ...

Posted on: January 21, 2016
Complex Grammar of the Genomic Language

A new study from Sweden's Karolinska Institutet shows that the "grammar" of the human genetic code is more complex than that of even the most intricately constructed spoken languages in the world. The findings, published in the journal Nature, explain why the human genome is so difficult to decipher - and contribute to the further understanding of how genetic differences affect the risk of developing diseases on an individual level."The genome contains all the information needed to build and maintain an ...

Posted on: January 19, 2016
View Archives

Back to Top

© 2016 Merion Matters

2900 Horizon Drive, King of Prussia PA 19406